Medicare Enrolled
Dr. Eric Langer, DO
Endocrinology · Sterling Heights, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Langer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Langer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Langer
Dr. Eric Langer is an endocrinology specialist in Sterling Heights, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Langer performed 2,620 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Langer received a total of $198,111 from 65 pharmaceutical and/or device companies across 1502 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Langer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 12% volume in MI
$198,111 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,620
Medicare services
Top 12% in MI for endocrinology
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
590 | $3 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
556 | $90 | $225 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
549 | $9 | $26 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
295 | $26 | $81 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
241 | $138 | $302 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
179 | $62 | $152 |
| Self-care/home management training, per 15 min Instruction provided to help patients manage their own care or daily activities at home. The service is billed in 15-minute increments. |
108 | $26 | $40 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
34 | $38 | $144 |
| New patient office visit, complex (60-74 min) | 33 | $158 | $432 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
22 | $114 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $108 | $347 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$198,111
Total received (2018-2024)
Avg $28,302/year across 7 years
Top 5% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
1,502
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,172
2023
$8,393
2022
$17,900
2021
$22,095
2020
$22,373
2019
$75,057
2018
$44,122
Payments by company (2024)
Ascendis Pharma Inc
$4,220
Medtronic, Inc.
$1,157
IBSA Pharma Inc.
$600
Novo Nordisk Inc
$323
SANOFI-AVENTIS U.S. LLC
$309
Lilly USA, LLC
$281
ABBVIE INC.
$194
Dexcom, Inc.
$155
Abbott Laboratories
$140
Neurocrine Biosciences, Inc.
$118
Boehringer Ingelheim Pharmaceuticals, Inc.
$89
Xeris Pharmaceuticals, Inc.
$81
Ascensia Diabetes Care Us Inc.
$75
Bayer Healthcare Pharmaceuticals Inc.
$75
Amgen Inc.
$61
Amneal Pharmaceuticals LLC
$57
AstraZeneca Pharmaceuticals LP
$43
Alexion Pharmaceuticals, Inc.
$39
Chiesi USA, Inc.
$39
Antares Pharma, Inc.
$28
Intra-Sana Laboratories
$21
Corcept Therapeutics
$21
Radius Health, Inc.
$17
RECORDATI_RARE_DISEASES_INC.
$17
CeQur Corporation
$13
Top 3 companies account for 73.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$133,784
Janssen Pharmaceuticals, Inc
$22,590
IBSA Pharma Inc.
$12,595
Medtronic MiniMed, Inc.
$4,401
Ascendis Pharma Inc
$4,289
Medtronic, Inc.
$2,784
Senseonics, Incorporated
$2,363
Lilly USA, LLC
$1,263
SANOFI-AVENTIS U.S. LLC
$1,241
Amgen Inc.
$1,230
AstraZeneca Pharmaceuticals LP
$1,148
Insulet Corporation
$808
Abbott Laboratories
$715
Dexcom, Inc.
$710
Ascensia Diabetes Care Us Inc.
$610
Amarin Pharma Inc.
$521
Radius Health, Inc.
$480
Boehringer Ingelheim Pharmaceuticals, Inc.
$479
ABBVIE INC.
$459
Merck Sharp & Dohme Corporation
$424
Amneal Pharmaceuticals LLC
$416
Corcept Therapeutics
$405
Valeritas, Inc.
$403
Xeris Pharmaceuticals, Inc.
$358
MannKind Corporation
$276
Bayer Healthcare Pharmaceuticals Inc.
$268
Becton, Dickinson and Company
$218
LifeScan, Inc.
$210
Antares Pharma, Inc.
$193
LIFESCAN, INC.
$188
Mannkind Corporation
$187
AbbVie Inc.
$169
RECORDATI_RARE_DISEASES_INC.
$156
Alexion Pharmaceuticals, Inc.
$153
Shire North American Group Inc
$135
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$133
Zealand Pharma US, Inc.
$120
Tandem Diabetes Care, Inc.
$118
Neurocrine Biosciences, Inc.
$118
AbbVie, Inc.
$104
DEXCOM, INC.
$93
Alvogen Inc
$87
Amryt Pharma Holdings Ltd
$84
EUSA Pharma (US) LLC
$83
Bayer HealthCare Pharmaceuticals Inc.
$77
PFIZER INC.
$51
Chiesi USA, Inc.
$39
Regeneron Healthcare Solutions, Inc.
$34
Embecta Corp.
$30
Takeda Pharmaceuticals U.S.A., Inc.
$29
Horizon Therapeutics plc
$28
EISAI INC.
$27
Clarus Therapeutics Inc.
$24
Nevro Corp.
$22
Intra-Sana Laboratories
$21
Averitas Pharma Inc.
$21
Ascendis Pharma, Inc.
$19
Ultragenyx Pharmaceutical Inc.
$18
Companion Medical, Inc.
$17
Endo Pharmaceuticals Inc.
$17
Alfasigma USA, Inc.
$16
Roche Diabetes Care, Inc.
$15
CeQur Corporation
$13
Strongbridge US INC.
$12
Acerus Pharmaceuticals Corporation
$12
Top 3 companies account for 85.3% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · AFREZZA · ASCENDA · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Belviq · CYCLOSET · CeQur Simplicity · Corlanor · DC ACCU-CHEK Aviva Connect Kits and Accessories · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · EVERSENSE E3 SMART TRANSMITTER KIT · Eversense · FARXIGA · FIASP · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · Guardian Sensor 3 · HUMULIN · HUMULIN R 500 · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · JUXTAPID · Kerendia · Korlym · LYUMJEV · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 670G System · Minimed 770G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · Natesto · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Otrexup · Ozempic · PRALUENT · Prolia · QUTENZA · RECORLEV · RELTONE 200 MG · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · t-slim insulin pump · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
78
County median income
$76,399
Nearest hospital to ZIP centroid (approximate)
THE BEHAVIORAL CENTER OF MICHIGAN
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Langer is a clinical cardiology specialist, with above-average Medicare volume (top 12% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Langer experienced with blood glucose test using hand-held instrument?
Based on Medicare claims data, Dr. Langer performed 590 blood glucose test using hand-held instrument services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Langer receive payments from pharmaceutical companies?
Yes. Dr. Langer received a total of $198,111 from 65 companies across 1,502 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Langer's costs compare to other endocrinologists in Sterling Heights?
Dr. Langer's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Langer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Sterling Heights
Browse endocrinologists in Sterling Heights ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
IBSA Pharma Inc. Payments to Doctors
See all physicians who received payments from IBSA Pharma Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology